Wedelolactone

Wedelolactone is a lipid of Polyketides (PK) class. Wedelolactone is associated with abnormalities such as CLEFT LIP, CONGENITAL HEALED and Hepatitis. The involved functions are known as Signal Transduction, Cell Cycle Arrest, Apoptosis, luciferase activity and Metabolic Inhibition. Wedelolactone often locates in Protoplasm and Smooth muscle (tissue). The associated genes with Wedelolactone are CFB gene, Candidate Disease Gene, JAK2 gene, STAT2 gene and STAT3 gene.

Cross Reference

Introduction

To understand associated biological information of Wedelolactone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Wedelolactone?

Wedelolactone is suspected in CLEFT LIP, CONGENITAL HEALED, Hepatitis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Wedelolactone

PubChem Associated disorders and diseases

What pathways are associated with Wedelolactone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Wedelolactone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Wedelolactone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Wedelolactone?

There are no associated biomedical information in the current reference collection.

What genes are associated with Wedelolactone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Wedelolactone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Wedelolactone

Download all related citations
Per page 10 20 50 100 | Total 111
Authors Title Published Journal PubMed Link
Maya S et al. Evaluation of neuroprotective effects of wedelolactone and gallic acid on aluminium-induced neurodegeneration: Relevance to sporadic amyotrophic lateral sclerosis. 2018 Eur. J. Pharmacol. pmid:30075221
Luo Q et al. Hepatoprotective Effect of Wedelolactone against Concanavalin A-Induced Liver Injury in Mice. 2018 Am. J. Chin. Med. pmid:29737211
Deng X et al. Wedelolactone inhibits osteoclastogenesis but enhances osteoblastogenesis through altering different semaphorins production. 2018 Int. Immunopharmacol. pmid:29702282
Zhu D et al. Wedelolactone Enhances Osteoblastogenesis through ERK- and JNK-mediated BMP2 Expression and Smad/1/5/8 Phosphorylation. 2018 Molecules pmid:29498687
Cheruvu HS et al. LC-MS/MS method for the simultaneous quantification of luteolin, wedelolactone and apigenin in mice plasma using hansen solubility parameters for liquid-liquid extraction: Application to pharmacokinetics of Eclipta alba chloroform fraction. 2018 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:29518720
Nehybová T et al. Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells. 2017 Int J Mol Sci pmid:28353647
Wei W et al. Protective effects of wedelolactone on dextran sodium sulfate induced murine colitis partly through inhibiting the NLRP3 inflammasome activation via AMPK signaling. 2017 Biomed. Pharmacother. pmid:28750357
Peng L et al. Wedelolactone, a plant coumarin, prevents vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia through Akt and AMPK signaling. 2017 Exp. Gerontol. pmid:28634089
Sarveswaran S et al. Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells. 2016 Mol. Cancer Ther. pmid:27474149
Ali F et al. Wedelolactone mitigates UVB induced oxidative stress, inflammation and early tumor promotion events in murine skin: plausible role of NFkB pathway. 2016 Eur. J. Pharmacol. pmid:27164422